U.S. Markets open in 8 hrs 15 mins

Izotropic Corporation (IZOZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4100-0.0400 (-8.89%)
At close: 03:40PM EDT

Izotropic Corporation

800 – 15355 24th Avenue
Suite 424
Surrey, BC V4A 2H9
833 496 2677

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. John McGraw M.Sc., Ph.D.Pres, CEO, Member of Advisory Board & Director17.68kN/AN/A
Ms. Jody Bellefleur CPA, CGA, CPAChief Financial Officer6.91kN/AN/A
Ms. Jaclyn ThastOperations Mang. & Corp. Sec.76.01kN/AN/A
Mr. Ali Reza SodagarLegal Advisor & Independent Director18.39kN/AN/A
Mr. Robert Louis ThastDirector & Special Advisor103.65kN/A1954
Dr. Younes Achkire Ph.D.Exec. VP of Product EngineeringN/AN/AN/A
Dr. Andrew M. HernandezHead of Imaging TechnologyN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.

Corporate Governance

Izotropic Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.